Classification
- Anatomical main groupVVarious
- Therapeutic subgroupV03
- Pharmacological subgroupV03A
- Chemical subgroupV03AF
- Chemical substanceV03AF01Mesna
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 11 registrations
- MesnaEurofarma Laboratorios S.A.
- MesnaNewcom Farmaceutica Ltda.
- MesnaBlau Farmacêutica S.A.
- MitexanBaxter Hospitalar Ltda
United States
FDA · 7 registrations
- Mesna1G/10ML · Injectable · Hikma
- Mesna100MG/ML · injectable · Mylan Institutional
- Mesnex100MG/ML · injectable · Baxter Hlthcare
- Mesnex400MG · tablet · Baxter Hlthcare
New Zealand
PHARMAC (NZ funding schedule) · 6 registrations
At a glance
- ATC code
- V03AF01
- ATC group
- Various
- Registers
- 8
- Historical lists
- 2
- Registrations
- 47
- With their own page
- 34
- Companies
- 28
All medicines with Mesna
Human medicines from every register that match Mesna by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
48 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Mesna | United States | 1G/10ML | Injectable | Marketed | Hikma |
| Mesna | United States | 100MG/ML | injectable | Marketed | Mylan Institutional |
| Mesna | United States | 400MG | tablet | Marketed | Ingenus Pharms LLC |
| Mesna | Brazil | Authorised | Eurofarma Laboratorios S.A. | ||
| Mesna | Brazil | Authorised | Blau Farmacêutica S.A. | ||
| Mesna | Brazil | Authorised | Newcom Farmaceutica Ltda. | ||
| Mesna for Injection | Canada | 100 MG / ML | Solution | Marketed | Fresenius Kabi Canada LTD |
| MESNA ALTAN 100 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG | Spain | 100 mg/ml | solución inyectable y para perfusión | Marketed | Altan Pharmaceuticals Sa |
| Mesna Altan 200MG/ML Solucion Para Nebulizacion y Para Instilacion Endotraqueopulmonar | Spain | 600 mg | solución para instilación endotraqueopulmonar | Marketed | Altan Pharmaceuticals Sa |
| Mesnex | United States | 100MG/ML | injectable | Marketed | Baxter Hlthcare |
| Mesnex | United States | 400MG | tablet | Marketed | Baxter Hlthcare |
| Mesna Stada® Concentrate Solution for Injection 400MG/4ML | Singapore | 400 mg/4 ml | injection, solution, concentrate | Authorised | DCH Auriga Singapore |
| Ifosfamide/Mesna KitCombination | United States | 1GM/20ML; 1GM/10ML (50MG/ML, 3GM/60ML; 1GM/10ML (50MG/ML | injectable | Not marketed | Teva Pharms USA |
| Ifex/Mesnex KitCombination | United States | 1GM/VIAL; 100MG/ML, 3GM/VIAL; 100MG/ML | injectable | Not marketed | Baxter Hlthcare |
| Uromitexan 100 MG/ML Solucion Inyectable y Para Perfusion | Spain | 100 mg | solución inyectable | Marketed | Baxter S.L. |
| MUCOFLUID 200 mg/ml SOLUCION PARA NEBULIZACION Y SOLUCION PARA INSTILACION ENDOTRAQUEOPULMONAR | Spain | 600 mg | solución para instilación endotraqueopulmonar | Marketed | Ionfarma S.L. |
| Uromitexan, omhulde tablet, 400 mg | Netherlands | Omhulde tablet | Authorised | Baxter B.V. | |
| Uromitexan, omhulde tablet, 600 mg | Netherlands | Omhulde tablet | Authorised | Baxter B.V. | |
| Uromitexan, oplossing voor injectie, 100 mg/ml | Netherlands | Oplossing voor injectie | Authorised | Medcor Pharmaceuticals B.V. | |
| Uromitexan, oplossing voor injectie 100 mg/ml | Netherlands | Oplossing voor injectie | Authorised | Baxter B.V. | |
| Uromitexan, oplossing voor injectie, 100 mg/ml | Netherlands | Oplossing voor injectie | Authorised | Medcor Pharmaceuticals B.V. | |
| Uromitexan 100 mg/ml otopina za injekciju/infuziju | Croatia | Otopina za injekciju / infuziju | Marketed | Baxter d.o.o. | |
| Mitexan | Brazil | Authorised | Baxter Hospitalar Ltda | ||
| Uromitexan | Canada | 100 MG / ML | Solution | Marketed | Baxter Corporation |
| Uromitexan | Canada | 100 MG / ML | Solution | Marketed | Baxter Corporation |